Rocket Pharmaceuticals, Inc. (RCKT)
NASDAQ: RCKT · Real-Time Price · USD
5.01
+0.48 (10.60%)
At close: Feb 27, 2026, 4:00 PM EST
4.910
-0.100 (-2.00%)
After-hours: Feb 27, 2026, 7:57 PM EST
Rocket Pharmaceuticals Market Cap
Rocket Pharmaceuticals has a market cap or net worth of $542.19 million as of February 27, 2026. Its market cap has decreased by -39.68% in one year.
Market Cap
542.19M
Enterprise Value
378.14M
1-Year Change
-39.68%
Ranking
Category
Stock Price
$5.01
Market Cap Chart
Since February 18, 2015, Rocket Pharmaceuticals's market cap has increased from $95.30M to $542.19M, an increase of 468.93%. That is a compound annual growth rate of 17.07%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 27, 2026 | 543.90M | 43.17% |
| Dec 31, 2025 | 379.90M | -66.84% |
| Dec 31, 2024 | 1.15B | -57.60% |
| Dec 29, 2023 | 2.70B | 82.44% |
| Dec 30, 2022 | 1.48B | 5.28% |
| Dec 31, 2021 | 1.41B | -53.56% |
| Dec 31, 2020 | 3.03B | 164.17% |
| Dec 31, 2019 | 1.15B | 94.21% |
| Dec 31, 2018 | 590.40M | 730.38% |
| Dec 29, 2017 | 71.10M | -56.73% |
| Dec 30, 2016 | 164.30M | -45.09% |
| Dec 31, 2015 | 299.20M | 213.96% |
View and export this data all the way back to 2015.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Ocugen | 603.31M |
| Alto Neuroscience | 599.27M |
| Neumora Therapeutics | 591.39M |
| Allogene Therapeutics | 588.79M |
| Fulcrum Therapeutics | 576.76M |
| Contineum Therapeutics | 576.43M |
| CorMedix | 567.28M |
| Altimmune | 546.01M |